BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

4.86
Delayed Data
As of Apr 24
 -0.04 / -0.82%
Today’s Change
3.95
Today|||52-Week Range
7.39
-1.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash54.7M30.5M23.7M53.6M
 
 
 
 
 
Short Term Investment Cash33.4M-25.6M-6.9M29.9M
 
 
 
 
 
Cash & Short Term Investments72.9M53.2M56.2M117.7M
 
 
 
 
 
 
ReceivablesReceivables9.5M6.2M8.8M6.1M
 
 
 
 
 
 
InventoriesInventories683.0K1.6M500.0K0.00
 
 
 
 
 
Current AssetsOther Current Assets6.2M4.9M1.4M1.4M
 
 
 
 
 
Current Assets89.3M65.9M66.9M125.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross14.2M19.4M14.8M14.9M
 
 
 
 
 
Depreciation-14.0M-14.2M-4.9M-5.3M
 
 
 
 
 
Other Assets6.3M5.8M4.1M2.2M
 
 
 
 
 
Total Assets136.9M124.6M89.8M178.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.8M9.3M4.3M6.3M
 
 
 
 
 
Short Term Debt30.0M30.0M28.2M35.2M
 
 
 
 
 
Accrued Expenses9.5M15.7M10.4M9.6M
 
 
 
 
 
Other Current Liabilities22.7M24.7M21.4M30.4M
 
 
 
 
 
Other Liabilities57.7M64.5M54.4M74.8M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.002.4M25.5M19.5M
 
 
 
 
Other Liabilities0.00329.0K244.0K155.0K
 
 
 
 
Total Liabilities61.2M76.8M88.3M94.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity75.6M47.7M1.6M83.8M
 
 
 
 
 
Total Shareholder Equity75.6M47.7M1.6M83.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding72.0M73.4M73.8M98.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.